国产老熟女老女人老人,换着玩人妻hd中文字幕,农民伯伯和乡下妹,男女免费观看做爰视频在线观看

The Fourth Amendment to the Chinese Patent Law: Summary of Key Points

Author:

Published on:

2023-03-13 14:20

The Standing Committee of the National People's Congress passed thedecision of 4th amendment to the Patent Law on October 17th,2020, which will take effect upon June 1, 2021. Please refer to the attachment for a complete table of the amended Chinese Patent Law in comparison with thecurrent version. We have also summarized the key points of thisamendment below for your kind review.

Improved system for protection of design patents:

-       the protection scope of design patents will beexpanded to include designs for the whole or part of a product (Article2, paragraph 4);

-       the terms for design patents will be extended fromten (10) years to fifteen (15) years (Article 42, paragraph 1);and

-       priority may be claimed from prior domestic design patent applications within six (6) months since the prior filingdate (Article 29, paragraph 2).

Newly added non-patentable subject matter:

-       "Substances obtained by means of nucleartransformation" has been amended to "methods of nucleustransformation and Substances obtained by means of nucleartransformation", indicating that both methods and products of nucleartransformation will be non-patentable subject matter (Article 25, paragraph 1).

New legal situation for not losing novelty:

-       “… … where it was first disclosed for thepurpose of public interest when a national emergency or any extraordinary stateof affairs occurs” (Article 24, paragraph 1).

Term compensation for invention patents andespecially for drug patents:

-       for unreasonable delays in the prosecution processof an invention patent, the patentee may request a term compensation forthe patent (Article 42, paragraph 2); and

-       for the time delay caused by the administrativeapproval of new drugs, a term of no more than five (5) years can berequested, where the total effective term of the patent since the approval ofthe new drug shall not exceed fourteen (14) years (Article 42, paragraph3).

Open licensing system of patents:

-       a patentee may voluntarily request the patentadministration department of the State Council to publish a withdrawableopen license statement” which may be accepted by any entity orindividual (Article 50);

-       the patentee may be granted a reduction or exemptionof patent annuities for the time being of patent open licensing (Article51, paragraph 2); and

-       open licensing is limited to non-exclusive licenses only (Article 51, paragraph 3).

Strengthenedenforcement against patent infringements:

-       the statute of limitations for patentinfringement and for disputes over requesting royalties for using a published,pre-grant invention patent application has been amended from two years to three(3) years, in consistency with the latest Civil Procedure Law (Article 74);

-       it has been clarified that thecompensation for patent infringement shall be calculated “according to theactual loss suffered by the right holder due to the infringement or theenrichment gained by the infringer due to the infringement”, which eliminatesthe debates about the priority of the calculation methods (Article 71,paragraph 1);

-       punitive damages may be determined for intentionalinfringements of serious circumstances at one to five times theamount of compensation determined in accordance with the law (Article 71,paragraph 1);

-       the statutory compensation for patentinfringement will be increased from 10,000 ~ 1,000,000 RMB to 30,000~5,000,000 RMB (Article 71, paragraph 2);

-       as for the burden of proof for determiningthe amount of compensation, the court may order the infringer to provideaccounting books and materials related to the infringement, where theinfringer, if failing to provide or provide false materials, may bear adverseconsequences as the court may then refer to the claims and evidences from theright holder to determine the amount of compensation (Article 71, paragraph 4);and

-       as for passing off patents, the upperlimit of administrative fines will be increased from four times to five times the illegal enrichment, or, if the illegal enrichment being zero or lessthan 50,000 RMB, from 200,000 RMB to 250,000 RMB (Article 68).

Patent linkage system for drugs:

-       during the marketing review and approval processof new drugs, the applicant of the marketing authorization, relevant patenteesor interested parties may request the patent administration department of theState Council or the court to confirm whether the drug falls within the scopeof patent protection, where the food and drug Administration may determinewhether to suspend the approval process based on the court’s decision (Article76, paragraphs 1 and 2); and

-       the food and drug administration and thepatent administration departments shall formulate specific measures forimplementing patent linkage of drugs (Article 76, paragraph 3).

Preventingpatent abuse:

-       patentees are required to apply for orenforce patent rights under the principle of good faith and must not abusetheir patent rights (Article 20, paragraph 1); and

monopolies constituted with the abuse of patent rights will be struckunder the Anti-Monopoly Law (Article 20, paragraph 2).
Copyright ? 2018 ADVANCE CHINA IP LAW OFFICE All Rights Reserved.
粵ICP備12081038號(hào)
国内精品人妻无码久久久影院导航| 老熟女重囗味hdxx70星空| xxoo电影| 稚嫩娇小哭叫粗大撑破h| 人妻熟妇乱又伦精品视频中文字幕| 韩国三级日本三级人与波| 性xxxxx大片免费视频| 无码熟妇人妻av在线网站| 无码人妻AⅤ一区二区三区蜜桃| 国产vivodeshd精品| 日本在线观看| 色综合久久久久综合99| 国内揄拍国内精品人妻试看| 精品无码成人片一区二区98| 公车系强女奷校花雪柔| 少妇av射精精品蜜桃专区| 换着玩人妻hd中文字幕| 日本三级吃奶头添泬播放| 女主播的yin荡日子np| 欧美精品中文字幕亚洲专区| 美女直播全婐app免费| 色欲色香天天天综合vvv| 粗暴进入娇小呻吟痛呼| sss极品尤物▌missa▌| 日本丰满岳乱妇在线观看| 国产成人午夜精品久久久久久| 两个男用舌头到我的蕊花| 亚洲日本va中文字幕久久| a级a片少妇高潮喷水片| 永久免费精品精品永久-夜色| 清明节的来历和风俗| 把朕的龙精含着h太子妃| 国产精品白丝久久AV网站| 被多个强壮的黑人灌满精| 呦vodafonewifi高清| 篮球鞋里满是室友白色的液体| 诱人的妺妺2中文在线观看车爱| 国产成人精品一区二三区| 免费真人泡妞软件| 强开小婷嫩苞又嫩又紧视频| 欧美在线 | 亚洲|